All Stories

  1. Biochemical and Immunological Insights into Capsular Polysaccharide of Streptococcus pneumoniae Serotype 38 (American Type 71)─An Emerging Nonvaccine Serotype
  2. Promoter characterization of relZ‐bifunctional (pp)pGpp synthetase in mycobacteria
  3. Novel edible multi-epitope vaccine construct against Enterococcus faecalis
  4. Tale of Twin Bifunctional Second Messenger (p)ppGpp Synthetases and Their Function in Mycobacteria
  5. An Unusual Presentation of Superior Mesenteric Venous Occlusion in Mild COVID-19
  6. Vitamin C and its therapeutic potential in the management of COVID19
  7. An Unusual Presentation of Superior Mesenteric Venous Occlusion in Mild COVID-19
  8. Possibility of Relapse of COVID19 in Asymptomatic Cases and Risk Assessment
  9. The extended (p)ppGpp family: New dimensions in Stress response
  10. Guidelines on newly identified limitations of diagnostic tools for COVID‐19 and consequences
  11. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
  12. 4-Hydroxy-2-pyridone Derivatives and the δ-pyrone Isostere as Novel Agents Against Mycobacterium smegmatis Biofilm Inhibitors
  13. The role of ω-subunit of Escherichia coli RNA polymerase in stress response
  14. Synthetic Arabinomannan Heptasaccharide Glycolipids Inhibit Biofilm Growth and Augment Isoniazid Effects in Mycobacterium smegmatis
  15. Novel Method for Quantitative Estimation of Biofilms
  16. Synthetic (p)ppGpp Analogue Is an Inhibitor of Stringent Response in Mycobacteria
  17. Vitamin C targets (p)ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis
  18. Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure
  19. BCG vaccine fails to prevent the reactivation of latent tuberculosis
  20. Differential binding of ppGpp and pppGpp toE. coliRNA polymerase: photo-labeling and mass spectral studies
  21. Novel pppGpp binding site at the C-terminal region of the Rel enzyme fromMycobacterium smegmatis
  22. Modifications in Trypsin Digestion Protocol for Increasing the Efficiency and Coverage
  23. Combined inhalation and oral supplementation of Vitamin A and Vitamin D: A possible prevention and therapy for tuberculosis
  24. Synthetic Glycolipids and (p)ppGpp Analogs: Development of Inhibitors for Mycobacterial Growth, Biofilm and Stringent Response
  25. Point of care testing for measurement of white blood cell count and C-reactive protein levels in blood
  26. Comments on “Serum Urea:Albumin Ratio as a Prognostic Marker in Critical Patients With Non-chronic Kidney Disease”
  27. VDR, RXR, Coronin-1 and Interferonγ Levels in PBMCs of Type-2 Diabetes Patients: Molecular Link between Diabetes and Tuberculosis
  28. Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: Implications in host-based chemotherapy
  29. Creatinine Estimation and Interference
  30. Streptomycin interference in Jaffe reaction — Possible false positive creatinine estimation in excessive dose exposure
  31. Synthesis of β-arabinofuranoside glycolipids, studies of their binding to surfactant protein-A and effect on sliding motilities of M. smegmatis